SMTL ID : 3lfn.1

Crystal structure of CDK2 with SAR57, an aminoindazole type inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.28 Å

Oligo State

monomer

Ligands

1 x A27: N-[6-(4-hydroxyphenyl)-5-phenyl-1H-indazol-3-yl]butanamide(Non-covalent)

A27.1: 16 residues within 4Å: Chain A: I.10, V.18, A.31, K.33, F.80, E.81, F.82, L.83, H.84, Q.85, Q.131, N.132, L.134, A.144, D.145, L.148 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:I.10, A:V.18, A:A.31, A:K.33, A:F.82, A:N.132, A:L.134, A:L.134, A:A.144 Hydrogen bonds: A:E.81, A:L.83, A:L.83, A:D.145 pi-Stacking: A:F.80 pi-Cation interactions: A:K.33

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lesuisse, D. et al., Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-03-02

Peptides

Cell division protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cell division protein kinase 2

Related Entries With Identical Sequence